Pirna, Germany

Martin Graefe


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Martin Graefe

Introduction

Martin Graefe, an inventive mind based in Pirna, Germany, has made significant contributions to the field of drug delivery technology. With a portfolio of two patents, he has focused on developing innovative solutions aimed at improving the efficiency and functionality of drug delivery devices.

Latest Patents

Among his notable inventions is the "Stopper arrangement for a drug delivery device." This invention comprises a stopper and a linear actuator that is coupled to a coupling arrangement. The configuration of this stopper arrangement is designed to be placed within the container of a drug delivery device. Specifically, the design aims to achieve a differential in frictional forces, optimized for when the linear actuator is contracting and expanding.

Another important patent is for a "Drug delivery device," which embodies his ongoing commitment to enhancing medication delivery systems. Both patents reflect Graefe's dedication to addressing challenges in pharmaceutical technologies.

Career Highlights

Martin Graefe is a key contributor at Sanofi-Aventis Deutschland GmbH, a global leader in the pharmaceutical industry. His work is pivotal in advancing drug delivery mechanisms that are vital for patient care and medication administration.

Collaborations

Graefe collaborates with fellow innovators Thomas Nagel and Rene Richter, among others, to drive forward-thinking research and development initiatives. Together, they are pushing the boundaries of drug delivery technology and working towards advancements that could benefit countless patients.

Conclusion

In conclusion, Martin Graefe is an accomplished inventor whose work significantly impacts the pharmaceutical industry. With his innovative spirit and collaborative approach, he continues to develop cutting-edge solutions that enhance drug delivery devices, ultimately improving patient health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…